IP Library › Granted Patent US 10,758,418
Granted Patent B2
US 10,758,418 · App. 15/458,609 · Granted Sep 1, 2020

Illuminated treatment probe for delivering laser energy

Inventors: Steven D. Vold (Bentonville, AR); Kenneth A. Peartree (Danville, CA); David Buzawa (San Jose, CA)
Assignees: IRIDEX Corporation; Steven D. Vold
A61F9/00821A61B90/30A61F9/008A61F2009/00868A61F2009/00891
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,758,418
App. No.
15/458,609
Filed
Mar 14, 2017
Granted
Sep 1, 2020
Kind
B2
Art Unit
3792
USPC
606/6
Abstract

The present invention generally relates systems, methods, and devices for treating an eye of a patient. In some embodiments, a system may be provided that includes a console for generating a treatment laser and an illumination light. The system may further include a treatment probe for delivering the illumination light to an eye so as to illuminate the ciliary process of the eye. With the illuminated ciliary process, the treatment probe may be aligned to deliver the treatment laser from the console to the ciliary process of the eye for the purpose of treating a patient for glaucoma. In some embodiments, a treatment probe may be provided with an illumination fiber for delivering light to specific portions of the eye or at desired angles in order to illuminate the ciliary process. In some embodiments a treatment probe may be configured to cooperate with a removable light pen for eye illumination.

Claims (40)

1. A treatment probe for treating an eye of a patient for glaucoma, the eye having, a sclera, a cornea, a pupil, a visual axis, and a ciliary process, the treatment probe comprising:

an elongate body defining a handle having a proximal end and a distal end;

a treatment fiber housed in the elongate body and configured for delivering a treatment laser energy to the eye from a distal end of the treatment fiber, wherein the treatment fiber is coupled to a treatment laser energy source;

an illumination light conduit housed in the elongate body and configured for delivering illumination light energy to the eye from a distal end of the illumination light conduit, wherein the illumination light conduit is coupled to an illumination light energy source; and

an output tip positioned on the distal end of the elongate body, the output tip having a contact surface that is configured to contact a surface of the eye;

wherein the output tip includes an opening for the distal end of the treatment fiber and an opening for the distal end of the illumination light conduit, wherein the opening for the distal end of the treatment fiber and the opening for the distal end of the illumination light conduit extend through the output tip so that said openings terminate at the contact surface;

wherein the distal end of the illumination light conduit terminates at the contact surface of the output tip; and

wherein the contact surface is configured when contacting the surface of the eye to align an axis of the handle with the visual axis of the eye, such that the treatment fiber and the illumination light conduit are configured to deliver, via the optical fiber openings terminating at the contact surface, treatment laser energy and illumination light energy parallel to the visual axis of the eye.

2. The treatment probe of claim 1 , wherein the distal end of the illumination light conduit is configured to deliver illumination light energy to illuminate an edge of the ciliary process and thereby provide a visual indication as to an exact location of the ciliary process within the eye through the pupil of the eye when the contact surface of the treatment probe couples with the surface of the eye.

3. The treatment probe of claim 1 , wherein the illumination light conduit is a single fiber that branches such that the illumination light conduit comprises a plurality of distal ends for delivering illumination light energy from a plurality of points.

4. The treatment probe of claim 3 , wherein the single fiber branches such that the illumination light conduit comprises a first distal end and a second distal end for delivering illumination light energy from a plurality of points; and wherein the first distal end and the second distal end of the illumination light conduit terminate on both sides of the distal end of the treatment fiber such that illumination light energy is directed in the same plane as the treatment laser energy.

5. The treatment probe of claim 1 , wherein the treatment probe includes one or more buttons for controlling the delivery of the treatment laser energy or illumination light energy to the eye.

6. The treatment probe of claim 1 , wherein a portion of the contact surface is constructed of a transparent material.

7. The treatment probe of claim 1 , wherein the opening for the distal end of the illumination light conduit is a first opening for a first distal end of the illumination light conduit and wherein the output tip includes a second opening for a second distal end of the illumination light conduit and wherein the first opening and the second opening are equally and laterally spaced on opposing sides of the opening for the treatment fiber.

8. The treatment probe of claim 7 , wherein openings in the output tip consist of the opening for the distal end of the treatment fiber, the first opening for the first distal end of the illumination light conduit, and the second opening for the second distal end of the illumination light conduit.

9. The treatment probe of claim 1 , wherein the distal end of the illumination light conduit is polished flush with the contact surface.

10. The treatment probe of claim 1 , wherein the treatment probe is configured so that when the contact surface contacts the surface of the eye, the distal end of the treatment fiber is aligned with the reference point to deliver the treatment laser energy to the reference point.

11. The treatment probe of claim 10 , wherein the treatment probe is configured so that when the contact surface contacts the surface of the eye, the distal end of the treatment fiber is aligned with the ciliary process.

12. The treatment probe of claim 1 , wherein the treatment probe is configured so that a treatment site for delivery of the treatment laser energy is offset from the reference point.

13. The treatment probe of claim 1 , wherein the distal end of the treatment fiber extends outward from the contact surface.

14. A treatment probe for treating an eye of a patient for glaucoma, the eye having, a sclera, a cornea, a pupil, a visual axis, and a ciliary process, the treatment probe comprising:

an elongate body defining a handle having a proximal end and a distal end;

a treatment fiber housed in the elongate body and configured for delivering a treatment laser energy to the eye from a distal end of the treatment fiber, wherein the treatment fiber is coupled to a treatment laser energy source;

an illumination light conduit housed in the elongate body and configured for delivering illumination light energy to the eye from a distal end of the illumination light conduit, wherein the illumination light conduit is coupled to an illumination light energy source; and

an output tip having a contact surface that is configured to contact a surface of the eye, the output tip including optical fiber openings comprising an opening for the distal end of the treatment fiber and an opening for the distal end of the illumination light conduit, wherein the optical fiber openings extend through the output tip so that the optical fiber openings terminate at the contact surface;

wherein the distal end of the illumination light conduit terminates at the contact surface of the output tip; and

wherein the contact surface is configured when contacting the surface of the eye to align an axis of the handle with the visual axis of the eye, such that the treatment fiber and the illumination light conduit are configured to deliver, via the optical fiber openings terminating at the contact surface, treatment laser energy and illumination light energy parallel to the visual axis of the eye.

15. The treatment probe of claim 14 , wherein the distal end of the illumination light conduit is configured to deliver illumination light energy to illuminate an edge of the ciliary process and thereby provide a visual indication as to an exact location of the ciliary process within the eye.

16. The treatment probe of claim 14 , wherein the illumination light conduit is a single fiber that branches such that the illumination light conduit comprises a plurality of distal ends for delivering illumination light energy from a plurality of points.

17. The treatment probe of claim 16 , wherein the single fiber branches such that the illumination light conduit comprises a first distal end and a second distal end for delivering illumination light energy from a plurality of points; and wherein the first distal end and the second distal end of the illumination light conduit terminate on both sides of the distal end of the treatment fiber such that illumination light energy is directed in the same plane as the treatment laser energy.

18. The treatment probe of claim 14 , wherein the opening for the distal end of the illumination light conduit is a first opening for a first distal end of the illumination light conduit and wherein the optical fiber openings in the output tip consist of the opening for the a distal end of the treatment fiber, the first opening for the first distal end of the illumination light conduit, and a second opening for a second distal end of the illumination light conduit.

19. The treatment probe of claim 18 , wherein the first opening and the second opening are equally and laterally spaced on opposing sides of the opening for the distal end of the treatment fiber.

20. The treatment probe of claim 14 , wherein the distal end of the treatment fiber extends outward from the contact surface.

21. The treatment probe of claim 14 , wherein a portion of the output tip is constructed of a transparent material.

22. The treatment probe of claim 14 , wherein the distal end of the illumination light conduit is polished flush with the contact surface.

23. The treatment probe of claim 14 , wherein the treatment probe is configured so that when the contact surface contacts the surface of the eye, the distal end of the treatment fiber is aligned with the reference point to deliver the treatment laser energy to the reference point.

24. The treatment probe of claim 23 , wherein the treatment probe is configured so that when the contact surface contacts the surface of the eye, the distal end of the treatment fiber is aligned with the ciliary process.

25. The treatment probe of claim 14 , wherein the treatment probe is configured so that a treatment site for delivery of the treatment laser energy is offset from the reference point.

26. The treatment probe of claim 1 , wherein the treatment laser energy source comprises a laser diode, and wherein the illumination light energy source comprises a light emitting diode.

27. The treatment probe of claim 1 , wherein the treatment laser energy source and the illumination light energy source are housed within the elongate body.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2017
From: PEARTREE, KENNETH A.; BUZAWA, DAVID
To: IRIDEX CORPORATION
Reel/Frame 041572/0864 →
Continuity (4)
Continuation 14630561 · Feb 24, 2015
Provisional Application 61945385 · Feb 27, 2014
Provisional Application 62018352 · Jun 27, 2014
Related Publication 20170181890A1 · Jun 29, 2017
Cited By (8)
US 12,226,345 US 12,245,813 US 12,245,974 US 12,465,522 US 12,465,523 US 12,642,699 US 12,728,037 US 12,746,154